Mårten Fernö
111 – 120 of 256
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up.
(
- Contribution to journal › Article
-
Mark
Nuclear Janus-Activated Kinase 2/Nuclear Factor 1-C2 Suppresses Tumorigenesis and Epithelial-to-Mesenchymal Transition by Repressing Forkhead Box F1.
(
- Contribution to journal › Article
-
Mark
Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort.
(
- Contribution to journal › Article
-
Mark
Cyclin A - an alternative to gene expression profiling for subdividing histological grade 2 breast cancer into groups with different prognosis
(
- Contribution to journal › Published meeting abstract
-
Mark
Modeling Prognostic Markers in Breast Cancer — Are We Using Them the Optimal Way?
(
- Contribution to journal › Published meeting abstract
-
Mark
Prediction of outcome after diagnosis of metachronous contralateral breast cancer
(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
Expression of Helix pomatia Lectin Binding Glycoproteins in Women with Breast Cancer in Relationship to Their Mood Group Phenotypes
(
- Contribution to journal › Article
-
Mark
Is the prognostic value of Ki-67 dependent on ER status and histological grade?
(
- Contribution to journal › Published meeting abstract
-
Mark
Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial.
(
- Contribution to journal › Article
-
Mark
Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer.
2009) In Modern Pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 22. p.1564-1574(
- Contribution to journal › Article